Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Coronary Artery Disease Drugs News Monitoring

Get by Email • RSS

Published on Jun 14, 2025

Gender Disparities and Treatment Gaps in LDL-C

Photo Credit: iStock.com/Naeblys The following is a summary of “Bridging Gaps in LDL-C Management: Utilization of Lipid-Lowering Therapies, Gender Disparities, and the Impact of Cardiology Visits on Secondary Prevention,” published in the June 2025 …

Source: Physician's Weekly - Neutral
Published on Jun 12, 2025

Application of Perioperative Comprehensive Care in Coronary Heart Disease Patients Undergoing Coronary Stent ...

Introduction Coronary heart disease (CHD), one of the most prevalent cardiovascular diseases globally, poses a significant threat to human health and life.1 With the advancement of medical technology, percutaneous coronary intervention (PCI) has emerged as …

Source: Dove Medical Press - Neutral
Published on Jun 13, 2025

FDA Expands Label for Moderna's mRNA RSV Vaccine to Include At-Risk Adults Aged 18 to 59 Years

The FDA has approved Moderna’s RSV vaccine, mRNA-1345 (mRESVIA), for adults aged 18–59 years who are at increased risk for respiratory syncytial virus (RSV)-related lower respiratory tract disease (LRD), extending the vaccine’s indication beyond its …

Source: Patient Care - Pending
Published on Jun 13, 2025

Shanghai Qilu Pharmaceutical describes new apolipoprotein A inhibitors

Cardiovascular Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. has divulged compounds acting as apolipoprotein A (ApoA; LPA) inhibitors reported to be useful for the treatment of hyperlipidemia, coronary heart disease, ischemic stroke and …

Source: BioWorld - Pending
Published on Jun 13, 2025

Study evaluating efficacy of Sirolimus-Coated Balloon against Drug-eluting Stent completes patient enrollment

Cleveland: An Italy-based research foundation, the Lodi has announced the completion of patient enrolment for a trial evaluating the safety and effectiveness of Sirolimus-Coated Balloon (SCB) in comparison with the Drug-eluting Stents. The trial has …

Source: ETHealthworld.com - Center-right
Published on Jun 13, 2025

FDA Approves First Triple-Drug Polypill for Initial Hypertension Treatment

The FDA has approved Widaplik, a polypill combining telmisartan, amlodipine, and indapamide, for the treatment of hypertension in adults, including as initial therapy. This is the first triple-combination pill approved for first-line treatment in patients …

Source: Medical Dialogues - Indeterminate
Published on Jun 14, 2025

What Happens to Your Body When You Eat Tuna Regularly

Tuna supports your heart health, mood, inflammation reduction and eye health. It can also help keep you fuller longer. It’s a good source of nutrients that many Americans often fall short on, like vitamin D and omega-3 fatty acids. Enjoy a classic tuna …

Source: EatingWell - Pending
Published on Jun 12, 2025

FDA Approves Triple Rx for Hypertension

The FDA has approved Widaplik, a triple-drug combination, for the treatment of hypertension in adults. Widaplik combines three drugs — telmisartan, amlodipine, and indapamide — into a single pill that will be available in three doses: 10/1.25/0.625 …

Source: Medscape - Neutral
Published on Jun 12, 2025

Discontinuation of Beta-Blockers Risky in Post-MI Patients with Preserved LVEF and Hypertension: ABYSS trial

A new study published in the European Heart Journal showed that patients with myocardial infarction (MI) and preserved left ventricular ejection fraction (LVEF) who discontinue beta-blocker therapy experience notable increases in heart rate and blood …

Source: Medical Dialogues - Indeterminate
Published on Jun 14, 2025

Effectiveness of an Individualized Diabetes Health Education Program Using Real-Time Continuous Glucose Monitoring in ...

Introduction Against the backdrop of China’s economic development, public health consciousness has markedly increased, particularly regarding proactive health management. This trend coincides with the nation’s escalating diabetes prevalence, driving …

Source: Dove Medical Press - Neutral
Published on Jun 12, 2025

Predicting Stroke-Associated Pneumonia in Acute Ischemic Stroke: A Machine Learning Model Development and Validation ...

Introduction Stroke-associated infection (SAI) is one of the major complications of stroke and is associated with increased mortality.1 Studies have shown that approximately 30% of stroke patients develop infections.2 Among these infections, stroke- …

Source: Dove Medical Press - Neutral
Published on Jun 14, 2025

Specials | Jun 14, 2025 | 24 min read TRANSFORM II Completes Enrollment: A New Era for Sirolimus-Coated Balloons

Others Specials Roughly 80% of patients undergoing percutaneous coronary interventions (PCI) fall into the vessel size category being studied in TRANSFORM II. New Delhi [India], June 14: The Fondazione Ricerca e Innovazione Cardiovascolare (RIC) has …

Source: Ahmedabad Mirror - Neutral
Published on Jun 11, 2025

The Synergistic and Attenuated Mechanism of Action of the Xihuang Pill in Dual Immunotherapy After Stenting for Advanced ...

Introduction Cholangiocarcinoma (CCA) is a malignant tumor originating from the epithelial cells of the bile duct. A study showed that the global incidence of CCA increased by 25% between 2007 and 2017.1 The incidence of CCA in China has also increased …

Source: Dove Medical Press - Neutral
Published on Jun 14, 2025

Relationship Between Glycosylated Hemoglobin Concentration and Prognosis of Acute ST-Segment Elevation Myocardial ...

Introduction Cardiovascular diseases (CVDs) are among the leading causes of morbidity and mortality worldwide and often present clinically as acute myocardial infarction (AMI) for the first time.1,2 ST-segment elevation myocardial infarction (STEMI) …

Source: Dove Medical Press - Neutral
Published on Jun 14, 2025

From cancer care to children’s diets, meet the team helping patients through food

Dietitians Week is a chance to reflect on the impact our work has in Lincolnshire, writes Rachel Thompson, lead dietitian for Lincolnshire Community and Hospitals NHS Group. Every year, Dietitians Week is held during the first week of June, making it a …

Source: Rutland Times - Neutral
Published on Jun 13, 2025

North America Interventional Cardiology Market Analysis 2025–2033 | Reaching $11.98 Billion by 2033 DataM Intelligence

North America's Interventional Cardiology Market is set to grow from USD 7.04B in 2024 to USD 11.98B by 2033, driven by rising Heart Disease and Tech AUSTIN, TX, UNITED STATES, June 13, 2025 /⁨EINPresswire.com⁩/ -- North America Interventional …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on Jun 13, 2025

Blood Based Biomarkers Report 2025: For Strategy Officers and Market Intelligence Teams

The Business Research Company's Blood Based Biomarkers Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 13, 2025 /⁨EINPresswire.com⁩/ -- What Does The Data On The …

Distribution channels: Business & Economy, Companies ...
Published on Jun 13, 2025

Men are not OK, report on premature deaths in Canada suggests

About 44 per cent of men living in Canada die prematurely, according to a new report from the Movember Institute of Men's Health. The report defines premature mortality as deaths in men before age 75. The deaths from cancer, coronary heart disease, …

Source: CBC/Radio-Canada - Public Broadcaster
Published on Jun 13, 2025

UH Harrington Heart & Vascular Institute First Site in to Provide More Accurate and Convenient PET MPI Cardiac ...

Newswise — CLEVELAND – University Hospitals Harrington Heart & Vascular Institute is the first site in the state of Ohio to clinically administer the FDA-approved Flyrcado™ (flurpiridaz F 18) injection to patients with known or suspected coronary …

Source: Newswise - Neutral

16 days 15:40:50

Featured Releases

Got News to Share? · Submit · See All

Published on June 15, 2025 - 14:33 GMT

WST 重要截止日期：全美審訊法律顧問 ROSEN 鼓勵損失 10 萬美元以上的 West Pharmaceutical Services, Inc. 投資者在對 WST 提出證券集體訴訟的重要截止日期前聘請律師

紐約, June 15, 2025 (GLOBE NEWSWIRE) -- 事因：全球投資者權益律師事務所 Rosen Law Firm 提醒在 2023 年 2 月 16 日至 2025 年 2 月 12 日（包括首尾兩日，下稱「集體訴訟期」）期間購買了 West Pharmaceutical Services, Inc. (NYSE: WST) 普通股之人士注意，重要的首席原告截止日期為 2025 年 7 月 7 日。影響：如果您在集體訴訟期間購買 West …

Distribution channels: Consumer Goods, Law ...
Published on June 15, 2025 - 14:33 GMT

WST IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors with ...

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive ( …

Distribution channels: Consumer Goods, Law ...

Published on June 15, 2025 - 14:00 GMT

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, ...

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST). Such investors are advised to contact Danielle Peyton at …

Distribution channels: Consumer Goods, Law ...
Published on June 15, 2025 - 14:00 GMT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw …

Distribution channels: Consumer Goods, Law ...

Published on June 15, 2025 - 14:00 GMT

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UroGen Pharma Ltd. of Class ...

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …

Distribution channels: Consumer Goods, Law ...
Published on June 15, 2025 - 15:22 GMT

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal ...

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study New late-breaking data at EAACI showed Dupixent …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 15:22 GMT

Communiqué : Dupixent a démontré sa supériorité par rapport au Xolair dans la rhinosinusite chronique avec polypes ...

EAACI : Le Dupixent a démontré sa supériorité par rapport au Xolair (omalizumab) dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute première étude respiratoire de phase 4 en comparaison directe …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 12:06 GMT

Redefining Fabry Disease Care: Gene Therapy and Long-Acting ERT Prepare to Disrupt Status Quo | Competitive Intellignece

Fabry disease treatment is advancing rapidly with gene therapies and next-gen ERTs promising durable efficacy, reduced burden, and broader mutation coverage. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Fabry Disease, a rare, X …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 822,460,015 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on June 15, 2025 - 18:08 GMT

CPR Classes Near Me Brings Premier CPR and First Aid Training to the Philadelphia Area

LANSDALE, PA, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- CPR Classes Near Me, a leading provider of certified CPR and First Aid training, has expanded into the Philadelphia region with the opening of a new training center located at 5 N …

Distribution channels: Business & Economy, Companies ...
Published on June 15, 2025 - 18:06 GMT

CPR Classes Near Me Opens New Location in Miami Lakes to Serve Hialeah and Surrounding Areas

MIAMI LAKES, FL, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- CPR Classes Near Me, a nationally trusted provider of American Heart Association (AHA) CPR and First Aid certification, has opened its newest location at 6625 Miami Lakes Dr #101 …

Distribution channels: Beauty & Hair Care, Companies ...
Published on June 15, 2025 - 18:06 GMT

CPR Classes Near Me Launches 31st Location in Louisville, KY – Offering AHA Certification for Individuals and Businesses

LOUISVILLE, KY, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- CPR Classes Near Me, a national leader in CPR and First Aid certification, is proud to announce the opening of its 31st training center, now open in Louisville at 1860 Mellwood …

Distribution channels: Business & Economy, Companies ...
Published on June 15, 2025 - 18:05 GMT

CPR Classes Near Me Expands to 32nd Location in Boston Area – Now Open in Needham, MA

NEEDHAM, MA, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- CPR Classes Near Me, one of the nation’s fastest-growing providers of CPR and First Aid certification, is proud to announce the opening of its 32nd training center, now serving the …

Distribution channels: Business & Economy, Companies ...
Published on June 15, 2025 - 18:05 GMT

ClearView Imaging Center offering free heart scans

Free Heart Artery Calcium Score For All Patients THE VILLAGES, FL, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- ClearView Imaging Center is proud to announce the grand opening of its state-of-the-art diagnostic imaging facility at 3325 …

Distribution channels: Business & Economy, Companies ...
Published on June 15, 2025 - 12:13 GMT

Mindworks NLP Offers a Smoking Cessation Group Hypnosis Live Event in Bellevue – June 21

Mindworks NLP announces a public group hypnosis seminar on June 21 to help participants quit smoking using powerful subconscious change techniques. BELLEVUE, WA, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- In a time when public health and …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on June 15, 2025 - 12:06 GMT

Redefining Fabry Disease Care: Gene Therapy and Long-Acting ERT Prepare to Disrupt Status Quo | Competitive Intellignece

Fabry disease treatment is advancing rapidly with gene therapies and next-gen ERTs promising durable efficacy, reduced burden, and broader mutation coverage. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Fabry Disease, a rare, X …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 12:06 GMT

Hunter Syndrome Therapeutics Evolve: Novel CNS-Targeting Therapies Set to Challenge Elaprase’s Market Monopoly

New CNS-penetrant therapies and gene therapies are poised to transform the Hunter Syndrome landscape, ending Elaprase’s long-standing treatment dominance. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Hunter Syndrome ( …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 12:06 GMT

Rewriting the Playbook in MPS I: CNS-Penetrant ERTs and Gene Therapies Usher in a New Treatment Era | CI Insights

Emerging CNS‑targeting ERTs and gene therapies for MPS I show promise for neurocognitive benefits, reduced treatment burden, and better outcomes. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Mucopolysaccharidosis type I (MPS I) …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 04:30 GMT

Thorncrest Dental Brings Advanced Laser Dentistry to Etobicoke with Picasso Soft Tissue Laser

ETOBICOKE, ONTARIO, CANADA, June 15, 2025 /⁨EINPresswire.com⁩/ -- Thorncrest Dental is proud to introduce the Picasso Soft Tissue Laser, a cutting-edge addition to its suite of dental technologies, now available to patients in the Etobicoke community. This …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 15:22 GMT

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal ...

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study New late-breaking data at EAACI showed Dupixent …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 15:22 GMT

Communiqué : Dupixent a démontré sa supériorité par rapport au Xolair dans la rhinosinusite chronique avec polypes ...

EAACI : Le Dupixent a démontré sa supériorité par rapport au Xolair (omalizumab) dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute première étude respiratoire de phase 4 en comparaison directe …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 15:21 GMT

Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (...

New late-breaking data at EAACI showed Dupixent outperformed Xolair across all primary and secondary efficacy endpoints of CRSwNP and in all asthma-related endpoints Dupixent also outperformed Xolair in improving such key signs and symptoms as nasal polyp …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 03:00 GMT

Tom Jackobs Offers Fractional Sales Management for Heart-Led Wellness Practices

New service helps mission-driven businesses improve sales performance without building a full in-house sales team. LOS ANGELES, CA, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Tom Jackobs, international sales strategist, is now offering …

Distribution channels: Book Publishing Industry, Business & Economy ...
Published on June 15, 2025 - 14:45 GMT

Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in ...

With up to three years of follow-up, a single dose of lonvo-z led to a 98% mean reduction in monthly HAE attack rate in all 10 patients All 10 patients were attack-free and treatment-free for a median of 23 months through the latest follow-up, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 12:00 GMT

New national report reveals critical gaps in asthma and COPD care

A new NRAP report has highlighted persistent and widespread gaps in the care of people with asthma and chronic obstructive pulmonary disease (COPD) across England and Wales, calling on integrated care boards and local health boards to mandate all eligible …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 15, 2025 - 12:00 GMT

RCP statement on Air India crash

RCP president, Dr Mumtaz Patel, said: ‘We are devastated by the plane crash in India today and the many lives it has claimed. Our thoughts and prayers are with everyone affected by this tragic incident. ‘We are directly contacting all our RCP members in …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 15, 2025 - 12:00 GMT

Latest ‘Focus on physicians’ survey closes with over 2000 responses from doctors across the UK

The 2025 ‘Focus on physicians’ survey – a joint project between the Royal College of Physicians (RCP), the Royal College of Physicians and Surgeons of Glasgow (RCPSG) and the Royal College of Physicians of Edinburgh (RCPE) – has now closed. The ‘Focus on …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 15, 2025 - 11:45 GMT

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP ...

– Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI) Congress describe mechanistic insights for greater potency with verekitug compared to tezepelumab – – Supports potentially differentiated profile of …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on June 15, 2025 - 11:11 GMT

D-Bal Max 2025: Exploring the Science and Safety behind a Popular And Legal Dianabol Steroid For Muscle Growth

Glasgow, June 15, 2025 (GLOBE NEWSWIRE) -- In the quest for enhanced athletic performance and muscle growth, many fitness enthusiasts and bodybuilders turn to supplements. D-Bal Max has emerged as a noteworthy option that claims to replicate the muscle- …

Distribution channels: